Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
12.71
-0.13 (-1.01%)
At close: Apr 28, 2026, 4:00 PM EDT
12.71
0.00 (0.00%)
Pre-market: Apr 29, 2026, 4:00 AM EDT
TNXP Revenue
In the year 2025, Tonix Pharmaceuticals Holding had annual revenue of $13.11M with 29.85% growth. Tonix Pharmaceuticals Holding had revenue of $5.39M in the quarter ending December 31, 2025, with 108.75% growth.
Revenue (ttm)
$13.11M
Revenue Growth
+29.85%
P/S Ratio
13.78
Revenue / Employee
$92,303
Employees
142
Market Cap
180.55M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| MacroGenics | 149.50M |
| Protalix BioTherapeutics | 52.74M |
| Precision BioSciences | 34.26M |
| Korro Bio | 6.39M |
| Cartesian Therapeutics | 2.80M |
| Humacyte | 2.04M |
TNXP News
- 5 days ago - Tonix Pharmaceuticals Presents Updates on Preclinical Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2026 - GlobeNewsWire
- 13 days ago - Tonix Pharmaceuticals Announces Publication of Steady-State Pharmacokinetics of TONMYA® After 20 Days of Daily Dosing in the Peer-Reviewed Journal, Clinical Pharmacology in Drug Development - GlobeNewsWire
- 4 weeks ago - Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Outlines Planned Adaptive Phase 2 Field Study of TNX-4800 for the Prevention of Lyme Disease, at the World Vaccine Congress Washington 2026 - GlobeNewsWire
- 4 weeks ago - Tonix Pharmaceuticals Announces First Participant Dosed in Phase 1 Investigator-Initiated Pharmacodynamic Study of TNX-1900 (Intranasal Potentiated Oxytocin) to Assess Potential for Treating Migraine and Craniofacial Pain - GlobeNewsWire
- 5 weeks ago - Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Washington 2026 - GlobeNewsWire
- 5 weeks ago - Tonix Pharmaceuticals to Present at BIO-Europe Spring 2026 - GlobeNewsWire
- 6 weeks ago - Tonix Pharmaceuticals Announces Oral Presentation and Two Poster Presentations on Preclinical Immuno-oncology Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026 - GlobeNewsWire
- 6 weeks ago - Tonix Pharmaceuticals Says Prescriptions For Chronic Pain Drug Top 4,200 Since Launch - Benzinga